Transcripts Provectus Biopharmaceuticals, Inc.

Stocks

Market Closed - OTC Markets 15:37:28 2026-06-02 EDT			5-day change	1st Jan Change
0.0620 ^USD	-7.32%		+3.33%	+10.91%

08-13	Provectus Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-07	Provectus Biopharmaceuticals, Inc. Highlights Peer-Reviewed Study Demonstrating Opposing Mechanistic Effects Of Rose Bengal Sodium At The Same Dose	CI

06-18	Provectus Biopharmaceuticals, Inc. - Shareholder/Analyst Call
25-06-18	Provectus Biopharmaceuticals, Inc. - Shareholder/Analyst Call
24-11-14	Provectus Biopharmaceuticals, Inc., Q4 2024 Earnings Call, Nov 14, 2024